Name: | Description: | Size: | Format: | |
---|---|---|---|---|
829.65 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Introdução: A Diabetes Mellitus (DM) é uma doença crónica em prevalência crescente, representando um desafio para a pessoa diabética e para o Serviço Nacional de Saúde (SNS), pela necessidade de cuidados contínuos. O acesso ineficiente aos Cuidados de Saúde Primários (CSP), poderá comprometer o controlo da doença. O acompanhamento farmacêutico pode ser importante na gestão da doença, prevenindo complicações.
Objetivos: Este estudo avalia o impacto da intervenção farmacêutica no controlo e na literacia em saúde de pessoas com DM2 e a associação entre a presença de médico de família e o controlo da doença.
Materiais e Métodos: O estudo envolveu 30 pessoas com DM2. Utilizou-se um desenho quase-experimental, com duas intervenções farmacêuticas, com intervalo de 3 meses.
Durante cada intervenção, foi aplicado um questionário para avaliar a literacia em saúde e testes de HbA1c para avaliar o controlo da doença.
Resultados: Após as duas intervenções, os valores de HbA1c reduziram significativamente de 6,3% para 6% (p=0,003), e houve uma melhoria significativa nas respostas do questionário de literacia em saúde (p<0,001). Os participantes com médico de família apresentaram níveis médios de HbA1c de 6,1%, enquanto aqueles sem médico apresentaram 6,8%. Embora essa diferença seja observável, estatisticamente não é significativa.
Conclusão: Verificaram-se os efeitos da intervenção farmacêutica na literacia em saúde e nos níveis de HbA1c das pessoas com DM2, mostrando resultados positivos e significativos. A análise de dados indicou que os farmacêuticos, em colaboração com os médicos, obtiveram melhores resultados no controlo da DM2.
Introduction: Diabetes Mellitus (DM) is a chronic disease with a growing prevalence, presenting a challenge for both diabetic individuals and the National Health Service (SNS) due to the need for continuous care. Inefficient access to Primary Health Care (PHC) may hinder disease control. Pharmacist follow-up can be crucial in disease management, helping to prevent complications. Objectives: This study assesses the impact of pharmaceutical intervention on disease control and health literacy in individuals with type 2 diabetes mellitus (DM2), and examines the association between having a family physician and diabetes control. Materials and Methods: The study involved 30 individuals with DM2. A quasiexperimental design was used, with two pharmaceutical interventions conducted over a three-month interval. During each intervention, a questionnaire was administered to assess health literacy, and HbA1c tests were performed to evaluate disease control. Results: After the two interventions, HbA1c values significantly decreased from 6.3% to 6% (p=0.003), and there was a significant improvement in health literacy questionnaire responses (p<0.001). Participants with a family physician had average HbA1c levels of 6.1%, while those without a physician had 6.8%. Although this difference is observable, it is not statistically significant. Conclusion: The effects of pharmaceutical intervention on health literacy and HbA1c levels in individuals with DM2 were demonstrated, showing positive and significant results. Data analysis indicated that pharmacists, in collaboration with physicians, achieved better outcomes in DM2 control.
Introduction: Diabetes Mellitus (DM) is a chronic disease with a growing prevalence, presenting a challenge for both diabetic individuals and the National Health Service (SNS) due to the need for continuous care. Inefficient access to Primary Health Care (PHC) may hinder disease control. Pharmacist follow-up can be crucial in disease management, helping to prevent complications. Objectives: This study assesses the impact of pharmaceutical intervention on disease control and health literacy in individuals with type 2 diabetes mellitus (DM2), and examines the association between having a family physician and diabetes control. Materials and Methods: The study involved 30 individuals with DM2. A quasiexperimental design was used, with two pharmaceutical interventions conducted over a three-month interval. During each intervention, a questionnaire was administered to assess health literacy, and HbA1c tests were performed to evaluate disease control. Results: After the two interventions, HbA1c values significantly decreased from 6.3% to 6% (p=0.003), and there was a significant improvement in health literacy questionnaire responses (p<0.001). Participants with a family physician had average HbA1c levels of 6.1%, while those without a physician had 6.8%. Although this difference is observable, it is not statistically significant. Conclusion: The effects of pharmaceutical intervention on health literacy and HbA1c levels in individuals with DM2 were demonstrated, showing positive and significant results. Data analysis indicated that pharmacists, in collaboration with physicians, achieved better outcomes in DM2 control.
Description
Dissertação para obtenção do grau de Mestre no Instituto Universitário Egas Moniz
Keywords
Diabetes Mellitus Tipo 2 Intervenção farmacêutica Literacia em saúde HbA1c